PML-RARalpha ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL

Related Experiment Video

Updated: Jun 19, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

E Schachter-Tokarz, C Kelaidi, B Cassinat

    Leukemia
    |October 30, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
    11:05

    Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

    Published on: January 7, 2019

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
    07:35

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

    Published on: October 11, 2018

    Related Experiment Videos

    Last Updated: Jun 19, 2026

    Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
    07:17

    Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

    Published on: August 23, 2024

    Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
    11:05

    Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

    Published on: January 7, 2019

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
    07:35

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

    Published on: October 11, 2018

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

    Articles linked to this work by shared authors, journal, and citation graph.

    The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.

    Familial cancer·2021

    Effect of the dietary combination of flaxseed and Ricinodendron heudelotii or Punica granatum seed oil on the fatty acid profile of eggs.

    Food chemistry·2020

    Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.

    Leukemia & lymphoma·2020

    Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.

    Leukemia research·2018

    Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016.

    Annales de dermatologie et de venereologie·2018

    Preclinical modeling of myelodysplastic syndromes.

    Leukemia·2017

    Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes inhibitor resistance mechanisms of acute myeloid leukemia cells.

    Leukemia·2026

    Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.

    Leukemia·2026

    Predicting long-term survival in primary myelofibrosis.

    Leukemia·2026

    Targeting the mitochondrial complex I subunit NDUFS2 potentiates FLT3 inhibition in acute myeloid leukaemia with FLT3 internal tandem duplication.

    Leukemia·2026

    Targeting the eIF4F translation initiation complex disrupts BCR::ABL1 translation and overcomes drug resistance in CML.

    Leukemia·2026

    Neoantigenic receptor ROR1 promotes cell growth through diverse and complementary mechanisms.

    Leukemia·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us